An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven't responded to oral ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...

The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...

Respondents who said they used other drugs recreationally were also likelier to say they used ketamine during the past year ...

A multidisciplinary approach, including ketamine withdrawal and symptom management, is essential to mitigate long-term ...

Heaps of ketamine, MDMA and illegal weed were seized by authorities as they busted a drug lab in Queens and arrested the ...

Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...

The US FDA has approved the first of its kind ketamine-based nasal spray which is supposed to act as a standalone therapy for ...

Exploring new treatment avenues has become crucial as mental health challenges such as depression and PTSD continue impacting ...

A Colne man who lost his football scholarship in America due to a ketamine addiction is warning people about the dangers of ...